Phio Pharmaceuticals Corp. — All Filings
863 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
25-NSE
3
3/A
4
4/A
424B2
424B3
424B4
424B5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
EFFECT
FWP
POS AM
POS EX
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SP 15D2
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | FORM 10-K | 0001437749-26-007078 | Mar 5, 2026 | Dec 31, 2025 |
| 8-K | FORM 8-K | 0001437749-26-007071 | Mar 5, 2026 | — |
| 8-K | FORM 8-K | 0001437749-26-004542 | Feb 18, 2026 | Feb 17, 2026 |
| SCHEDULE 13G/A | — | 0001649553-26-000030 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001213900-26-016522 | Feb 13, 2026 | — |
| 8-K | FORM 8-K | 0001437749-26-003575 | Feb 10, 2026 | — |
| 4 | — | 0001683168-26-000813 | Feb 6, 2026 | Feb 5, 2026 |
| 4 | — | 0001683168-26-000811 | Feb 6, 2026 | Feb 5, 2026 |
| 4 | — | 0001683168-26-000809 | Feb 6, 2026 | Feb 5, 2026 |
| 4 | — | 0001683168-26-000807 | Feb 6, 2026 | Feb 5, 2026 |
| 4 | — | 0001683168-26-000805 | Feb 6, 2026 | Feb 5, 2026 |
| 4 | — | 0001683168-26-000803 | Feb 6, 2026 | Feb 5, 2026 |
| 8-K | FORM 8-K | 0001437749-26-001500 | Jan 20, 2026 | — |
| 4 | — | 0001683168-26-000013 | Jan 2, 2026 | Dec 31, 2025 |
| 4 | — | 0001683168-25-009349 | Dec 29, 2025 | Dec 23, 2025 |
| 8-K | FORM 8-K | 0001437749-25-038607 | Dec 23, 2025 | — |
| SCHEDULE 13G/A | — | 0001493152-25-027252 | Dec 11, 2025 | — |
| 424B3 | FORM 424B3 | 0001683168-25-008889 | Dec 4, 2025 | — |
| EFFECT | — | 9999999995-25-003514 | Dec 3, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-036329 | Nov 25, 2025 | — |
| SCHEDULE 13G/A | — | 0001493152-25-024820 | Nov 24, 2025 | — |
| 4 | — | 0001683168-25-008639 | Nov 24, 2025 | Nov 21, 2025 |
| S-3 | REGISTRATION STATEMENT | 0001683168-25-008586 | Nov 20, 2025 | — |
| 4 | — | 0001683168-25-008537 | Nov 19, 2025 | Nov 18, 2025 |
| 10-Q | FORM 10-Q | 0001437749-25-034857 | Nov 13, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001437749-25-034848 | Nov 13, 2025 | — |
| D | — | 0001123292-25-000633 | Nov 12, 2025 | — |
| SCHEDULE 13G/A | — | 0001493152-25-021629 | Nov 12, 2025 | — |
| SCHEDULE 13G | — | 0001649553-25-000206 | Nov 10, 2025 | — |
| SCHEDULE 13G/A | — | 0001213900-25-107723 | Nov 7, 2025 | — |
| SCHEDULE 13G/A | — | 0001493152-25-021091 | Nov 6, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-033600 | Nov 6, 2025 | Nov 3, 2025 |
| 8-K | FORM 8-K | 0001437749-25-032662 | Nov 3, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-032512 | Oct 31, 2025 | — |
| 4/A | — | 0001683168-25-006986 | Sep 15, 2025 | Sep 11, 2025 |
| 8-K | FORM 8-K | 0001683168-25-006985 | Sep 15, 2025 | Sep 11, 2025 |
| 4 | — | 0001683168-25-006961 | Sep 15, 2025 | Sep 11, 2025 |
| 4 | — | 0001683168-25-006959 | Sep 15, 2025 | Sep 11, 2025 |
| 4 | — | 0001683168-25-006958 | Sep 15, 2025 | Sep 11, 2025 |
| 4 | — | 0001683168-25-006957 | Sep 15, 2025 | Sep 11, 2025 |
| 4 | — | 0001683168-25-006956 | Sep 15, 2025 | Sep 11, 2025 |
| 4 | — | 0001683168-25-006955 | Sep 15, 2025 | Sep 11, 2025 |
| 4 | — | 0001683168-25-006954 | Sep 15, 2025 | Sep 11, 2025 |
| S-8 | REGISTRATION STATEMENT | 0001683168-25-006846 | Sep 11, 2025 | — |
| 8-K | CURRENT REPORT | 0001683168-25-006641 | Sep 3, 2025 | — |
| DEFA14A | ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS | 0001683168-25-006511 | Aug 28, 2025 | — |
| 424B3 | PROSPECTUS | 0001683168-25-006496 | Aug 27, 2025 | — |
| EFFECT | — | 9999999995-25-002730 | Aug 22, 2025 | — |
| CORRESP | — | 0001683168-25-006371 | Aug 21, 2025 | — |
| UPLOAD | — | 0000000000-25-008902 | Aug 21, 2025 | — |